Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythroblastosis Fetalis, Rh Disease”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT03297671
What this trial is testing

The Prevention of Rh Disease of Newborns in Pakistan

Who this might be right for
Rhesus DiseaseAnti-D (Rh) Antibodies Affecting Care of Mother
Aga Khan University 1,654
Large-scale testing (Phase 3)Study completedNCT00295516
What this trial is testing

Doppler or Amniocentesis to Predict Fetal Anemia

Who this might be right for
Rh Isoimmunization
University of Toronto 157
Testing effectiveness (Phase 2)Study completedNCT03842189
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 25
Not applicableUnknownNCT04600674
What this trial is testing

Delayed Cord Clamping in Rhesus Disease of the Newborn

Who this might be right for
Rhesus Isoimmunization
Benha University 30
Large-scale testing (Phase 3)UnknownNCT03104426
What this trial is testing

EPO-4-Rhesus Study

Who this might be right for
Erythroblastosis, FetalErythroblastosis Fetalis, Rh DiseaseErythroblastosis Fetalis Due to RH Antibodies+1 more
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 42